- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
Patent holdings for IPC class A61P 21/00
Total number of patents in this class: 5831
10-year publication summary
|
188
|
300
|
415
|
406
|
443
|
595
|
601
|
557
|
493
|
224
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dyne Therapeutics, Inc. | 258 |
101 |
| Société des Produits Nestlé S.A. | 10043 |
87 |
| Research Institute at Nationwide Children's Hospital | 626 |
87 |
| Sarepta Therapeutics, Inc. | 392 |
71 |
| Novartis AG | 10338 |
51 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3154 |
47 |
| Avidity Biosciences, Inc. | 187 |
46 |
| Centre National de La Recherche Scientifique | 10914 |
45 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
45 |
| Osaka University | 3289 |
43 |
| The Regents of the University of California | 20590 |
35 |
| Genethon | 256 |
29 |
| President and Fellows of Harvard College | 6060 |
28 |
| F. Hoffmann-La Roche AG | 7847 |
26 |
| Takeda Pharmaceutical Company Limited | 2718 |
26 |
| Kyoto University | 2898 |
26 |
| Edgewise Therapeutics, Inc. | 66 |
25 |
| Scholar Rock, Inc. | 133 |
24 |
| Sorbonne Universite | 1374 |
22 |
| The Trustees of the University of Pennsylvania | 4403 |
21 |
| Other owners | 4946 |